[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
C4x Discovery Holdings Plc LSE:C4XD London Ordinary Share GB00BQQ2RV18 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 28.75 28.50 29.00 29.25 28.75 28.75 199,277 15:29:57
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -9.6 -8.1 - 65

C4x Discovery Share Discussion Threads

Showing 2451 to 2475 of 2625 messages
Chat Pages: 105  104  103  102  101  100  99  98  97  96  95  94  Older
DateSubjectAuthorDiscuss
12/4/2021
08:33
It's certainly interesting to see that IL17 has leapfrogged NRF2 in the portfolio and so hopefully we still have another late stage prospect in partnership discussions. It's a very significant up front payment again and the 11m euros of preclinical milestones should mean cash keeps coming in the door. Massively significant for a company who's market cap is still under 60m. We are still so far under the radar....look how quiet this bb is despite this further huge step forward. Well done Clive.... not only chairing the vaccine task force and helping return the country to normal but also bringing home the bacon here.
bamboozler
12/4/2021
08:22
It's just a matter of time this is a huge deal.
grity
12/4/2021
08:22
It's just a matter of time this is a huge deal.
grity
12/4/2021
08:21
True, early days but still shows the potential for the drug discovery system. Also, the fact a pharma have come in at such an early stage suggests they were keen to get involved as early as possible. Competition with other pharmas?
alloa2003
12/4/2021
08:19
Great to see another partnership announced and the as Alloa points out it confirms C4X was not just a one hit wonder.
bamboozler
12/4/2021
08:18
the fact that there are preclinical milestones suggests this is not ready for phase1 yet, it could still fail. Hopefully NRF2 is still in play and they do a deal soon.
davemac3
12/4/2021
08:08
Without the fund raising dilution we would have been a lot higher then again without the extra funds the company would not have survived. Not only is the deal potentially huge but this confirms the system works - one big deal might have been seen as a fluke but two shows the system works. Obv both deals need to pass cinical trials, etc but Clive Dix always saids he was confident they would pass preclinical trials as not new treatments, just new methods of delivery.
alloa2003
12/4/2021
08:03
Well worth the wait and more to follow hopefully - as mentioned, this was not the deal we were expecting.
alloa2003
12/4/2021
07:15
Interesting that there are preclinical milestones. also not the deal we were expecting
davemac3
12/4/2021
07:10
Today's rns looks a splendid deal
ayl30
06/4/2021
09:10
sickle cell disease getting some media attention through the unfortunate disappearance of london schoolboy, who carries the disease. c4xd at the forefront of finding remedies to tackle this disease.
astorcourt
22/3/2021
23:46
Just checking, aside from the interim and final results, we have not had a business update on its own since 01 Oct 2019. There was an update on the INDV clinical trials on 09 Dec 2019 but other than that the news flow has been poor. Oh yes, we have had placing news but no business updates other than with the half year and full year results. Sometimes I wish they were a little more open with what is happening behind the scenes rather than leaving the market in the dark.
alloa2003
22/3/2021
22:31
Interesting that the shares seem very steady even when things go quiet - havent yet seen any real profit taking. Is there still demand for the shares behind the scenes?
alloa2003
17/3/2021
07:54
https://www.rpharms.com/resources/podcast-central/pharmsci-today
bloomberg2
16/3/2021
21:51
Even clarifying the maximum income for the INDV deal would see the share price rocket. One or two more deals of that size would put us in a different league. The kicker with this company will be the cumulatve repetitive income from each individual molecule going forwards.
alloa2003
16/3/2021
14:28
@Toffee. CD was very particular with his choice of words in his last video in 2020. He said we could expect "two or maybe three deals in the next few years" and if I remember correctly he qualified that by saying they should be approximately the same size as the Indivior licence deal.
t0pgrader
16/3/2021
11:44
Three deals a year! None since that video at the end of 2018
toffeeman
16/3/2021
11:17
He has been making all of the right noises for years, just needs to deliver now. On balance I think he will deliver. However, his approach is not news driven which drives share prices. We will only hear about deals when they have been signed.
alloa2003
15/3/2021
22:03
https://youtu.be/ntljiVNXgvI
bloomberg2
15/3/2021
20:54
Makes you wonder if there has been a stock overhang for a while and it is just being cleared now.
alloa2003
15/3/2021
15:00
Nice move again today
ayl30
15/3/2021
14:26
There are some chunky share deals going through. There must be huge demand in the background to mop these sales up. I would love to know what is going on behind the scenes.
alloa2003
15/3/2021
11:04
Interim results due end of April! Nothing price sensitive usually made with interims and final results!!
bloomberg2
15/3/2021
10:48
Will the company issue an operational update this year?
astorcourt
15/3/2021
09:48
Big punting again
bloomberg2
Chat Pages: 105  104  103  102  101  100  99  98  97  96  95  94  Older
ADVFN Advertorial
Your Recent History
LSE
C4XD
C4x Discov..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211028 14:53:44